Obalon Therapeutics, Inc.
(NASDAQ : OBLN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.21%450.031.0%$776.20m
MDTMedtronic Plc -0.42%117.460.6%$566.33m
ABTAbbott Laboratories -0.09%119.070.8%$549.39m
DHRDanaher Corp. -0.94%217.610.7%$489.17m
BSXBoston Scientific Corp. -0.43%38.651.0%$399.98m
ISRGIntuitive Surgical, Inc. -0.30%724.942.3%$380.90m
ALGNAlign Technology, Inc. 0.97%532.546.3%$367.54m
BDXBecton, Dickinson & Co. 0.23%242.221.0%$342.63m
SYKStryker Corp. -0.87%240.771.3%$299.95m
DXCMDexCom, Inc. -0.69%366.167.8%$297.57m
IDXXIDEXX Laboratories, Inc. -0.69%494.573.8%$257.25m
BAXBaxter International, Inc. -0.49%76.771.8%$234.80m
ZBHZimmer Biomet Holdings, Inc. -1.27%157.731.7%$226.84m
EWEdwards Lifesciences Corp. -1.02%83.390.4%$213.93m
AAgilent Technologies, Inc. -1.64%117.341.6%$202.28m

Company Profile

Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded on January 2, 2008 and is headquartered in Carlsbad, CA.